SNES

MKT CAP:$8M

SenesTech, Inc.

Market Cap

$8M

Basic Materials·Chemicals - Specialty·🇺🇸 United States·NASDAQ

Materials·Chemicals·🇺🇸·NASDAQ

Stock Price

$1.55-$0.66 (-29.79%)

Apr 24, 2026

Company Details

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquar...

CEO

Joel L. Fruendt

IPO Date

Dec 8, 2016

Website

www.senestech.com

Key Metrics TTM

Revenue

$2M

+19.6% YoY

Net Income

-$6M

EPS (Diluted)

-$2.78

Free Cash Flow

-$6M

Revenue / Share

$0.43

Gross Margin

62.5%

Operating Margin

-292.9%

Net Margin

-287.4%

FCF Margin

-265.1%

P/S

3.7x

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 12, 2026

$2M+19.6%EPS -$1.95

Q4 2025

Mar 12, 2026

$421.0K-16.0%EPS -$0.35

Q3 2025

Nov 10, 2025

$690.0K+43.2%EPS -$0.28

Q2 2025

Aug 7, 2025

$625.0K+36.2%EPS -$0.87

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$195.0K	$90.0K	-$2M
Q2 22	$277.0K	$136.0K	-$3M
Q3 22	$250.0K	$122.0K	-$3M
Q4 22	$297.0K	$116.0K	-$2M
Q1 23	$233.0K	$92.0K	-$2M
Q2 23	$305.0K	$142.0K	-$2M
Q3 23	$360.0K	$176.0K	-$2M
Q4 23	$295.0K	$129.0K	-$2M
Q1 24	$415.0K	$135.0K	-$2M
Q2 24	$459.0K	$249.0K	-$2M
Q3 24	$482.0K	$315.0K	-$2M
Q4 24	$501.0K	$305.0K	-$1M
Q1 25	$485.0K	$313.0K	-$2M
Q2 25	$625.0K	$409.0K	-$2M
Q3 25	$690.0K	$433.0K	-$1M
Q4 25	$421.0K	$233.0K	-$2M

Valuation

Quarter	P/S	P/E
Q1 22	13.8x	—
Q2 22	9.0x	—
Q3 22	5.6x	—
Q4 22	5.9x	—
Q1 23	4.1x	—
Q2 23	4.6x	—
Q3 23	21.9x	—
Q4 23	5.5x	—
Q1 24	2.6x	—
Q2 24	2.8x	—
Q3 24	1.1x	—
Q4 24	1.3x	—
Q1 25	1.7x	—
Q2 25	11.4x	—
Q3 25	9.1x	—
Q4 25	4.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$2M	-$2M
Q2 22	-$2M	-$2M
Q3 22	-$2M	-$2M
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q2 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$2M	-$2M
Q1 24	-$2M	-$2M
Q2 24	-$2M	-$2M
Q3 24	-$1M	-$1M
Q4 24	-$1M	-$1M
Q1 25	-$2M	-$2M
Q2 25	-$1M	-$1M
Q3 25	-$1M	-$1M
Q4 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q1 22	$66.0K
Q2 22	$80.0K
Q3 22	$21.0K
Q4 22	$39.0K
Q1 23	$1.0K
Q2 23	$20.0K
Q3 23	$93.0K
Q4 23	$35.0K
Q1 24	$2.0K
Q2 24	$39.0K
Q3 24	$28.0K
Q4 24	$15.0K
Q1 25	$36.0K
Q2 25	$47.0K
Q3 25	$42.0K
Q4 25	$13.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+121.6%	+31.2%
Q2 22	+73.1%	+13.6%
Q3 22	+57.2%	+18.9%
Q4 22	+75.7%	-8.1%
Q1 23	+19.5%	-9.9%
Q2 23	+10.1%	-19.1%
Q3 23	+44.0%	-19.4%
Q4 23	-0.7%	-17.0%
Q1 24	+78.1%	-0.9%
Q2 24	+50.5%	-10.6%
Q3 24	+33.9%	-12.2%
Q4 24	+69.8%	-13.4%
Q1 25	+16.9%	-4.9%
Q2 25	+36.2%	+8.6%
Q3 25	+43.2%	+0.4%
Q4 25	-16.0%	+30.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$224.0K	114.9%
Q2 22	$206.0K	74.4%
Q3 22	$140.0K	56.0%
Q4 22	$141.0K	47.5%
Q1 23	$166.0K	71.2%
Q2 23	$170.0K	55.7%
Q3 23	$131.0K	36.4%
Q4 23	$88.0K	29.8%
Q1 24	$85.0K	20.5%
Q2 24	$0	0.0%
Q3 24	$73.0K	15.1%
Q4 24	$80.0K	16.0%
Q1 25	$91.0K	18.8%
Q2 25	$90.0K	14.4%
Q3 25	$0	0.0%
Q4 25	$36.0K	8.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$516.0K	$2M	$20.0K	—
Q2 22	$431.0K	$2M	$225.0K	—
Q3 22	$452.0K	$2M	$261.0K	—
Q4 22	$460.0K	$2M	$125.0K	—
Q1 23	$387.0K	$2M	$54.0K	—
Q2 23	$381.0K	$2M	$63.0K	—
Q3 23	$379.0K	$2M	$82.0K	—
Q4 23	$81.0K	$2M	$118.0K	—
Q1 24	$370.0K	$2M	$73.0K	—
Q2 24	$467.0K	$1M	$71.0K	—
Q3 24	$451.0K	$1M	$80.0K	—
Q4 24	$424.0K	$1M	$64.0K	—
Q1 25	$418.0K	$1M	$64.0K	—
Q2 25	$427.0K	$2M	$64.0K	—
Q3 25	$400.0K	$1M	$77.0K	—
Q4 25	$453.0K	—	—	$2M

Revenue by Geography

Quarter	United States
Q2 24	$459.0K
Q3 24	$482.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$7M	$22.0K	$7M
Q2 22	$5M	$22.0K	$5M
Q3 22	$3M	$22.0K	$3M
Q4 22	$5M	$0	$5M
Q1 23	$3M	$0	$3M
Q2 23	$2M	$0	$2M
Q3 23	$2M	$0	$2M
Q4 23	$5M	$0	$5M
Q1 24	$4M	$0	$4M
Q2 24	$2M	$0	$2M
Q3 24	$3M	$0	$3M
Q4 24	$1M	$0	$1M
Q1 25	$2M	$0	$2M
Q2 25	$6M	$0	$6M
Q3 25	$7M	$3M	$10M
Q4 25	$8M	$994.0K	$9M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	5K	+0.0%	+50.1%
Q2 22	5K	+0.0%	+0.3%
Q3 22	5K	0.0%	+0.2%
Q4 22	6K	+12.0%	+12.0%
Q1 23	13K	+125.0%	+152.0%
Q2 23	24K	+86.0%	+368.6%
Q3 23	35K	+46.0%	+584.0%
Q4 23	514K	+1376.8%	+8922.3%
Q1 24	514K	+0.1%	+3912.9%
Q2 24	514K	+0.0%	+2058.0%
Q3 24	729K	+41.8%	+1995.7%
Q4 24	729K	0.0%	+41.9%
Q1 25	1M	+78.2%	+152.7%
Q2 25	2M	+42.7%	+260.5%
Q3 25	5M	+151.7%	+540.0%
Q4 25	5M	+11.9%	+616.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$7.5K	26
Q2 22	$10.7K	26
Q3 22	$9.6K	26
Q4 22	$10.2K	29
Q1 23	$8.0K	29
Q2 23	$10.5K	29
Q3 23	$12.4K	29
Q4 23	$11.8K	25
Q1 24	$16.6K	25
Q2 24	$18.4K	25
Q3 24	$19.3K	25
Q4 24	$21.8K	23
Q1 25	$21.1K	23
Q2 25	$27.2K	23
Q3 25	$30.0K	23
Q4 25	$18.3K	23

Revenue / Employee